Literature DB >> 17620242

Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital.

Dror Marchaim1, Shiri Navon-Venezia, Azita Leavitt, Inna Chmelnitsky, Mitchell J Schwaber, Yehuda Carmeli.   

Abstract

OBJECTIVES: To perform a molecular and epidemiologic investigation of multidrug-resistant (MDR) Acinetobacter baumannii in an institution were polyclonal outbreaks have been observed and determine whether these polyclonal outbreaks had an endogenous origin or were caused by in-hospital patient-to-patient transmission.
DESIGN: Retrospective analysis of prospectively collected data.
SETTING: An epidemiologic and genotypic investigation of incident cases of MDR A. baumannii infection in an Israeli university tertiary care center. PATIENTS: Hospitalized patients with MDR A. baumannii isolated from clinical samples during a 13-week period, from April 15, 2003, through July 15, 2003. INTERVENTION: All patients with new MDR A. baumannii infections were recruited, and isolates were typed using pulsed-field gel electrophoresis. Data on in-hospital movements and consultations were extracted from computerized databases. Quantification of transmission opportunities (TOPs), defined as encounters between an established carrier and a future carrier of MDR A. baumannii, and analysis of ward clusters were performed.
RESULTS: We studied 96 MDR A. baumannii isolates, which belonged to 18 different pulsed-field gel electrophoresis clones. In 65% of cases, TOPs involving patients with the same clone were demonstrated, which is significantly greater than the number of TOPs involving patients with different clones (P=.01).
CONCLUSION: Although outbreaks of MDR A. baumannii infection may be polyclonal, we believe that patient-to-patient transmission explains most cases of transmission. Polyclonal local outbreaks reflect several clonal outbreaks occurring simultaneously. The cause of polyclonal outbreaks of A. baumannii infections clustered by ward and time remains to be explained.

Entities:  

Mesh:

Year:  2007        PMID: 17620242     DOI: 10.1086/518970

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  23 in total

1.  Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain.

Authors:  Pilar Villalón; Sylvia Valdezate; Maria J Medina-Pascual; Virginia Rubio; Ana Vindel; Juan A Saez-Nieto
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

2.  Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.

Authors:  Tara Reddy; Teena Chopra; Dror Marchaim; Jason M Pogue; George Alangaden; Hossein Salimnia; Dina Boikov; Shiri Navon-Venezia; Robert Akins; Philip Selman; Sorabh Dhar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

3.  Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii.

Authors:  Evan S Snitkin; Adrian M Zelazny; Clemente I Montero; Frida Stock; Lilia Mijares; Patrick R Murray; Julie A Segre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

4.  Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.

Authors:  Dror Marchaim; Teena Chopra; Jason M Pogue; Federico Perez; Andrea M Hujer; Susan Rudin; Andrea Endimiani; Shiri Navon-Venezia; Jatinder Hothi; Jessica Slim; Christopher Blunden; Maryann Shango; Paul R Lephart; Hossein Salimnia; Deborah Reid; Judy Moshos; Wasif Hafeez; Suchitha Bheemreddy; Ting-Yi Chen; Sorabh Dhar; Robert A Bonomo; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

5.  Patient-to-Patient Transmission of Acinetobacter baumannii Gastrointestinal Colonization in the Intensive Care Unit.

Authors:  Anthony D Harris; J Kristie Johnson; Lisa Pineles; Lyndsay M O'Hara; Robert A Bonomo; Kerri A Thom
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 6.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

7.  Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility.

Authors:  Christin N McQueary; Benjamin C Kirkup; Yuanzheng Si; Miriam Barlow; Luis A Actis; David W Craft; Daniel V Zurawski
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

8.  Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program.

Authors:  Won Suk Choi; Su Hyun Kim; Eun Gyong Jeon; Myeung Hee Son; Young Kyung Yoon; Jung-Yeon Kim; Mi Jeong Kim; Jang Wook Sohn; Min Ja Kim; Dae Won Park
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

9.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

10.  Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility.

Authors:  Jon P Furuno; Joan N Hebden; Harold C Standiford; Eli N Perencevich; Ram R Miller; Anita C Moore; Sandra M Strauss; Anthony D Harris
Journal:  Am J Infect Control       Date:  2008-09       Impact factor: 2.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.